Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2019-11-16 2019-11-12
Drug Identification Number 02243942 02243942
Brand name TEVETEN TEVETEN
Common or Proper name Eprosartan mesylate Eprosartan mesylate
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients EPROSARTAN EPROSARTAN
Strength(s) 600MG 600MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28 CA 28 CA
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-11-15 2019-11-15
Actual start date
Estimated end date 2019-11-22 2019-11-22
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments